RYM
RYTHM, Inc.28.98
+3.01+11.6%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
62.28MP/E (TTM)
-Basic EPS (TTM)
-17.62Dividend Yield
0%Recent Filings
8-K
Q4 revenue jumps 164%
RYTHM reported Q4 2025 revenue from continuing operations of $10.7 million, up 164% from $4.0 million prior quarter, with gross profit hitting $8.0 million at 75% margin. Licensing fees fueled the surge after acquiring brands like RYTHM and incredibles, generating $7.8 million yearly. Operating loss widened to $12.9 million on $8.5 million impairment. Cash stands at $32.2 million.
10-K
FY2025 results
RYTHM exploded revenue to $17.3M in FY2025 ended December 31, 2025, up from $18K, powered by $9.5M non-licensing from hemp-derived THC products and $7.8M related-party licensing from May/August brand acquisitions—yet posted a $33M net loss amid $34M SG&A and $8.5M asset impairments. Q4 momentum built on licensing ramp-up post-August VCP deal, driving 59% gross margins while cultivation/extraction shifted to discontinued ops with $1.5M net gain. $80M convertible notes loom through 2027, backed by $32M cash. Debt servicing ramps quarterly. Regulatory flips threaten hemp-derived sales.
8-K
Q3 revenue doubles to $4M
RYTHM reported Q3 revenue from continuing operations at $4.0M, up 98% from $2.0M in Q2, yet posted an $8.9M operating loss amid brand acquisitions. Acquired RYTHM, Dogwalkers, Beboe IP on August 27; renamed itself September 2, trading as RYM. Se ñorita THC Margaritas rolled out to 1,000+ Circle K stores and Minnesota Targets. Cash sits at $35.6M; revenue doubled, costs exploded.
10-Q
Q3 FY2025 results
RYTHM kicked off continuing operations with $4.0M revenue in Q3 FY2025 ended September 30, 2025, up from zero a year ago (derived), driven by $3.5M non-licensing and $0.5M licensing from related-party brands like incredibles; gross margin hit 34.0%. Yet SG&A ballooned to $10.3M on $3.1M related-party services and $1.8M intangibles amortization, fueling an $8.9M operating loss—wider than last year's $1.2M (derived)—while $1.1M interest and $0.7M warrant fair-value hit drove net loss to $10.7M or $(5.33) per share on 2.0M diluted shares. Cash swelled to $35.6M after $80M notes (10% rate, related-party heavy) funded $55M brand buys from Green Thumb (MC Brands May $5.1M cash; VCP August $50M cash, intangibles over 2-7 years). Debt totals $90M; ops burned $20.5M. Licensing hinges on cannabis licensees.
8-K
Recasts Extraction as discontinued
RYTHM recasts its FY 2024 10-K to reclassify legacy Extraction Business as discontinued operations under ASC 205-20, following board approval on March 30, 2025. This strategic shift—after selling Cultivation assets December 31, 2024—cleanses historicals, isolating hemp beverage focus. Restatements hit MD&A and financials in Exhibit 99.1. Forward risks lurk in subsequent filings.
ACB
Aurora Cannabis Inc.
5.53+0.41
AGCO
AGCO Corporation
106.46-1.87
AGRI
AgriFORCE Growing Systems Ltd.
2.33+0.29
BNC
CEA Industries Inc.
6.42-0.03
HYFM
Hydrofarm Holdings Group, Inc.
2.44+0.40
MAJI
Marijuana Inc.
0.05-0.02
NGHI
New Green Hemp Inc.
0.30+0.00
NKLAQ
Nikola Corporation
0.00-0.00
NMHI
Nature's Miracle Holding Inc.
0.08+0.01
UGRO
urban-gro, Inc.
0.35+0.05